Astellas Submits Fezolinetant New Drug Application to U.S. FDA
Go back to Astellas Submits Fezolinetant New Drug Application to U.S. FDA| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 14.72 +0.18 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.54 | 52 Week High | $19.40 | |||
| Open | $14.67 | 52 Week Low | $12.50 | |||
| Day High | $14.79 | P/E | N/A | |||
| Day Low | $14.34 | EPS | $0.00 | |||
| Volume | 76,662 | |||||
